Aperio Introduces Industry’s First Digital IHC Solution With Integrated Image Analysis for Quantification of Breast Cancer
In yet another step towards full adoption of digital pathology in the clinical workspace Aperio recently announced a complete solution for reading and IHC stains with integrated reporting for a wide variety of tissue types and stains.
Pathologists now can read and report digital slides with added ease of reporting in the same application. Adoption has been occurring in niches and this is another barrier to entry that has been crossed – the ability to interpret and report in a more functional clinical workflow. The added advantage of "real-time onsite image analysis" provides another deliverable over "analog pathology".
Abbreviated press release:
Slides to Reports in Less Than 30 Minutes
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, is pleased to announce the launch of a digital pathology solution for Immunohistochemistry (IHC) designed specifically for the clinical market. Aperio’s digital IHC solution is the only commercially available FDA-cleared system allowing pathologists to run quantitative IHC image analysis while reading slides on a computer monitor.
A digital IHC system significantly streamlines clinical workflow. By using a single system to read digital IHC slides, perform quantitative image analysis, and create professional reports, pathologists can provide faster turn-around times, more informed decision-making, and accurate and consistent test results.
Eric F. Glassy, MD, medical director at Pathology Inc., stated, "After switching to Aperio's digital IHC solution from a different computer-assisted technology, we immediately experienced improved efficiency. More importantly, the interpretation algorithms offer far more control and accuracy, and the reporting capability is superior. We especially appreciate the ability to link thumb nail images on the PDF file to the actual whole slide images. The power and flexibility are simply remarkable."
The digital IHC system includes FDA-cleared algorithms for HER2, ER and PR stained breast specimens for diagnosing digital slides for clinical use in pathology. In addition, the system comes with a suite of image analysis algorithms that can be tuned for different tissue types (e.g. breast, colon, prostate), stains (e.g. HER2, ER, PR, Ki-67, P53, EGFR), reagents (e.g. Dako, Ventana) or to correlate algorithm results with other test methods (e.g. FISH, CISH).
“An integrated system is key to providing an efficient workflow for pathologists, and a major advantage over add-on image analysis systems,” said Dirk Soenksen, CEO of Aperio. “Pathologists can now use Aperio’s sophisticated cell-based image analysis capabilities with the click of a button while reading a slide.”